Autologous bone-marrow mononuclear stem cell therapy in patients with stroke: a meta-analysis of comparative studies.

Both the BM-MNCs and medical stroke treatment have similar outcomes in terms of safety and short-term efficacy, while the effect of therapy is significant only after 6 months. More well-designed, large sized RCTs are needed to confirm the efficacy of stem cell therapy over long periods of follow-up.